Facts about the Alzheimer's disease... Jul 08
Lecanemab is indicated for the treatment of Alzheimer’s Disease... Jun 26
This collaboration aims to discover and develop novel KATP channel activators with the potential to treat rare diseases... Feb 24
Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukaemia ... Feb 10
On the off chance that you’re sleeping habits aren't only a way of life, that is, you can't nod off and rise ... Nov 24
The two partners want to pool their expertise in order to identify and develop new monoclonal antibodies for cancer therapy... Nov 24
ISD and Biogen will work together to develop ISD's lead compound, ISD 017, which is being developed to treat severe lupus - systemic lupus erythematosus (... Nov 24
The amfAR Foundation for AIDS Research, to test the ability of Vyrologix (leronlimab) to mediate a functional HIV cure... Nov 24
The campaign will be carried out in rural and urban areas by the teams formed earlier for Intensive community survey campaigns in the state... Oct 24
The figures indicated a daily increase of nearly 8,000 new infections... Mar 28
-Advertisements-
Friday, April 19, 2024
